XILIO THERAPEUTICS INC. - COMMON STOCK
1.1400
14-二月-25 16:45:00
15 分钟延时
股票
-0.1500
-11.63%
今日范围
1.0000 - 1.3000
ISIN
N/A
来源
NASDAQ
-
Xilio Therapeutics Announces Multiple Masked T Cell Engager Programs
12 2月 2025 07:35:00 条件 Nasdaq GlobeNewswire
-
12 2月 2025 07:33:00 条件 Nasdaq GlobeNewswire
-
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 2月 2025 16:30:00 条件 Nasdaq GlobeNewswire
-
Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17 1月 2025 16:30:00 条件 Nasdaq GlobeNewswire
-
Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
10 1月 2025 17:00:00 条件 Nasdaq GlobeNewswire
-
Xilio Therapeutics Appoints Caroline Hensley as Chief Legal Officer
16 12月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 12月 2024 16:30:00 条件 Nasdaq GlobeNewswire
-
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2024 Financial Results
07 11月 2024 09:05:00 条件 Nasdaq GlobeNewswire
-
04 10月 2024 09:05:00 条件 Nasdaq GlobeNewswire
-
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 10月 2024 16:15:03 条件 Nasdaq GlobeNewswire
-
Xilio Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
28 8月 2024 16:01:00 条件 Nasdaq GlobeNewswire
-
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2024 Financial Results
08 8月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Xilio Therapeutics Appoints Aoife Brennan, M.D., and James Shannon, M.D., to its Board of Directors
13 6月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results
14 5月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
01 4月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing
28 3月 2024 07:05:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >